位置:首页 > 蛋白库 > R213B_DANRE
R213B_DANRE
ID   R213B_DANRE             Reviewed;        5061 AA.
AC   A0A0R4I9Y1;
DT   16-MAR-2016, integrated into UniProtKB/Swiss-Prot.
DT   20-JAN-2016, sequence version 1.
DT   03-AUG-2022, entry version 39.
DE   RecName: Full=E3 ubiquitin-protein ligase rnf213-beta {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q63HN8};
DE            EC=3.6.4.- {ECO:0000250|UniProtKB:Q63HN8};
DE   AltName: Full=E3 ubiquitin-lipopolysaccharide ligase rnf213-beta {ECO:0000305};
DE            EC=2.3.2.- {ECO:0000250|UniProtKB:Q63HN8};
DE   AltName: Full=Mysterin-B;
DE   AltName: Full=Mysterin-beta {ECO:0000303|PubMed:26530008};
DE   AltName: Full=RING finger protein 213-B {ECO:0000305};
DE   AltName: Full=RING finger protein 213-beta {ECO:0000303|PubMed:21799892};
GN   Name=rnf213b;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen;
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C., Muffato M.,
RA   Collins J.E., Humphray S., McLaren K., Matthews L., McLaren S., Sealy I.,
RA   Caccamo M., Churcher C., Scott C., Barrett J.C., Koch R., Rauch G.J.,
RA   White S., Chow W., Kilian B., Quintais L.T., Guerra-Assuncao J.A., Zhou Y.,
RA   Gu Y., Yen J., Vogel J.H., Eyre T., Redmond S., Banerjee R., Chi J., Fu B.,
RA   Langley E., Maguire S.F., Laird G.K., Lloyd D., Kenyon E., Donaldson S.,
RA   Sehra H., Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Elliot D., Threadgold G.,
RA   Harden G., Ware D., Begum S., Mortimore B., Kerry G., Heath P.,
RA   Phillimore B., Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S.,
RA   Pelan S., Griffiths G., Smith M., Glithero R., Howden P., Barker N.,
RA   Lloyd C., Stevens C., Harley J., Holt K., Panagiotidis G., Lovell J.,
RA   Beasley H., Henderson C., Gordon D., Auger K., Wright D., Collins J.,
RA   Raisen C., Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J., Babbage A.,
RA   Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S., Wray P.,
RA   Ellington A., Matthews N., Ellwood M., Woodmansey R., Clark G., Cooper J.,
RA   Tromans A., Grafham D., Skuce C., Pandian R., Andrews R., Harrison E.,
RA   Kimberley A., Garnett J., Fosker N., Hall R., Garner P., Kelly D., Bird C.,
RA   Palmer S., Gehring I., Berger A., Dooley C.M., Ersan-Urun Z., Eser C.,
RA   Geiger H., Geisler M., Karotki L., Kirn A., Konantz J., Konantz M.,
RA   Oberlander M., Rudolph-Geiger S., Teucke M., Lanz C., Raddatz G.,
RA   Osoegawa K., Zhu B., Rapp A., Widaa S., Langford C., Yang F.,
RA   Schuster S.C., Carter N.P., Harrow J., Ning Z., Herrero J., Searle S.M.,
RA   Enright A., Geisler R., Plasterk R.H., Lee C., Westerfield M.,
RA   de Jong P.J., Zon L.I., Postlethwait J.H., Nusslein-Volhard C.,
RA   Hubbard T.J., Roest Crollius H., Rogers J., Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the human
RT   genome.";
RL   Nature 496:498-503(2013).
RN   [2]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=21799892; DOI=10.1371/journal.pone.0022542;
RA   Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T.,
RA   Hashikata H., Matsuura N., Yamazaki S., Toyoda A., Kikuta K., Takagi Y.,
RA   Harada K.H., Fujiyama A., Herzig R., Krischek B., Zou L., Kim J.E.,
RA   Kitakaze M., Miyamoto S., Nagata K., Hashimoto N., Koizumi A.;
RT   "Identification of RNF213 as a susceptibility gene for moyamoya disease and
RT   its possible role in vascular development.";
RL   PLoS ONE 6:E22542-E22542(2011).
RN   [3]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=26530008; DOI=10.1038/srep16161;
RA   Kotani Y., Morito D., Yamazaki S., Ogino K., Kawakami K., Takashima S.,
RA   Hirata H., Nagata K.;
RT   "Neuromuscular regulation in zebrafish by a large AAA+ ATPase/ubiquitin
RT   ligase, mysterin/RNF213.";
RL   Sci. Rep. 5:16161-16161(2015).
CC   -!- FUNCTION: Atypical E3 ubiquitin ligase that can catalyze ubiquitination
CC       of both proteins and lipids, and which is involved in various
CC       processes, such as lipid metabolism, angiogenesis and cell-autonomous
CC       immunity. Acts as a key immune sensor by catalyzing ubiquitination of
CC       the lipid A moiety of bacterial lipopolysaccharide (LPS) via its RZ-
CC       type zinc-finger: restricts the proliferation of cytosolic bacteria,
CC       such as Salmonella, by generating the bacterial ubiquitin coat through
CC       the ubiquitination of LPS. Ubiquitination of LPS triggers cell-
CC       autonomous immunity, such as antibacterial autophagy, leading to
CC       degradation of the microbial invader (By similarity). Involved in lipid
CC       metabolism by regulating fat storage and lipid droplet formation; act
CC       by inhibiting the lipolytic process (By similarity). Also regulates
CC       lipotoxicity by inhibiting desaturation of fatty acids. Also acts as an
CC       E3 ubiquitin-protein ligase via its RING-type zinc finger. Involved in
CC       the non-canonical Wnt signaling pathway in vascular development: acts
CC       by mediating ubiquitination and degradation of proteins downstream of
CC       rspo3, leading to inhibit the non-canonical Wnt signaling pathway and
CC       promoting vessel regression. Also has ATPase activity; ATPase activity
CC       is required for ubiquitination of LPS (By similarity).
CC       {ECO:0000250|UniProtKB:A0A0R4IBK5, ECO:0000250|UniProtKB:Q63HN8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q63HN8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q63HN8};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066;
CC         Evidence={ECO:0000250|UniProtKB:Q63HN8};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q63HN8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q63HN8}. Lipid droplet
CC       {ECO:0000250|UniProtKB:Q63HN8}.
CC   -!- DOMAIN: Composed of an N-terminal stalk, a dynein-like core comprised
CC       of two catalytically active and four inactive ATPase domains, and a C-
CC       terminal E3 module. The ATPase regions do not generate movement but
CC       rather act like an intricate molecular 'switch'.
CC       {ECO:0000250|UniProtKB:E9Q555}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for the ubiquitin-
CC       protein ligase activity. {ECO:0000250|UniProtKB:Q63HN8}.
CC   -!- DOMAIN: The RZ-type (RNF213-ZNFX1) zinc-finger is required for the
CC       ubiquitination of the lipid A moiety of bacterial lipopolysaccharide
CC       (LPS). {ECO:0000250|UniProtKB:Q63HN8}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype (PubMed:21799892,
CC       PubMed:26530008). No vascular phenotype (PubMed:21799892,
CC       PubMed:26530008). {ECO:0000269|PubMed:21799892,
CC       ECO:0000269|PubMed:26530008}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CU459056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   SMR; A0A0R4I9Y1; -.
DR   STRING; 7955.ENSDARP00000127221; -.
DR   PaxDb; A0A0R4I9Y1; -.
DR   ZFIN; ZDB-GENE-110822-1; rnf213b.
DR   eggNOG; ENOG502QQ65; Eukaryota.
DR   OMA; DCENSIF; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:A0A0R4I9Y1; -.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   GO; GO:0140042; P:lipid droplet formation; ISS:UniProtKB.
DR   GO; GO:0120323; P:lipid ubiquitination; ISS:UniProtKB.
DR   GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0002040; P:sprouting angiogenesis; IBA:GO_Central.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0098792; P:xenophagy; ISS:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR22605; PTHR22605; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS51981; ZF_RZ; 1.
PE   3: Inferred from homology;
KW   Angiogenesis; ATP-binding; Cytoplasm; Hydrolase; Immunity; Lipid droplet;
KW   Lipid metabolism; Metal-binding; Multifunctional enzyme;
KW   Nucleotide-binding; Reference proteome; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..5061
FT                   /note="E3 ubiquitin-protein ligase rnf213-beta"
FT                   /id="PRO_0000435805"
FT   ZN_FING         3957..3997
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         4429..4501
FT                   /note="RZ-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
FT   REGION          1..334
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        21..51
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        59..91
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        124..199
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..286
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        301..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        4462
FT                   /note="Nucleophile; for E3 ubiquitin-lipopolysaccharide
FT                   ligase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
FT   BINDING         1923..1928
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         2023
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         2074
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         2417
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         2492
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3957
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3960
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3972
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3974
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3977
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3980
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3993
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         3996
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q555"
FT   BINDING         4451
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
FT   BINDING         4455
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
FT   BINDING         4471
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
FT   BINDING         4474
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01325"
SQ   SEQUENCE   5061 AA;  577550 MW;  11C60D242B171DE7 CRC64;
     MTRKRKSGKK GKPLAQKKEA QKRGGSTSSS TTQKEGAQKG DGSSSSSTTQ KDGAQKRDDS
     TSSSSTAQKE EGQKSDGSTS SSTTNKEGAQ KRDGSTSSRL QKKGPQKRKG STSSSRAHSR
     SRSKSKQTSY PSQARSRSHG QHNISTTESG PLSKEAQTQT SASLLVDKDT QTETVGQASQ
     QTQTEINGNT ETAEVSQPPQ LSHEDVEMEG TVQPRTKGSE SDGEKEESVK RKKRKLSEIG
     EPAKETEDST KLSHECEEKV GDNQKNEDTN KHYGGDSLKD LKSVTEEPKS YAAAAATGKT
     GKVSKEQTNQ IEANQDSTME SKSTQRKPSP VRAPAGPPML TFYIYAVLDK RFRFNEQYDS
     LFLDYGNGNI KLQMKHFNIG KDGYLIEATF SVEDSAVRGG TIQYKYVVQQ RQNQKSEIAV
     RYIEVPSYTT EKEFHLYEGY ISCSSTVSIT EWMMSLFHSE QKAVYKGWET SAHVLLDRIF
     LKWHPSNEES NMTFVQHLRS YKNAFESGFV EFPGNYTPFP IKVSELISAK LRMILKKESE
     ALRTSESLDG VKSEALSVAL SVFKVCCGCD VDLSLKDWGK LCQVVSECMG SFGEIQTTQT
     APFINTVTGL MNLCAKKLIT EVVLLVPVLH LLRNSEVNEA GPGSSMDEQR WTGLENISYQ
     SFRERIRGLP DKRRMILKLI KDNLPMTKDN PKLLKSWLSL VAFEDVSEFV QLTGSFPELL
     IQSLMCRIIE AEKNTDANRT EKNLEVTGKV LNLLLKSIKK DRERIMKTEQ LKLILQCCCN
     VHKSVCKTAR LVPQYKVTVL SFQLLLKMAE IVYDGFFKGG EQMKQHQNEV LSKLNIIQED
     FRKWRVELLL KPLMQTTGFT YPREMELWND LYGIESSIPG VTERWKGFLD HDLRRRISQI
     SDTDKIVVYV LVTSAKAVEN SHANIQSCLK ELCEAAIKNQ CQSKKEGTLL CHLFSKTISW
     PVLSSIIVES AACFGEDHKG RLLDPQSAIN FFLSQDKWNE WKLEDGASQL IAESQSFLGR
     LIQTLCQGSI PLGHLKTIFK YKTQFQKLYN QYKNNNKEMN VSISVSDLLS QREDDLKAFE
     QQKGYMTNLI NMLGKISDVI NVPELSSLEE IAKTNVQEVA LDKLVEVETY FSKDDLKKNN
     TRRVLFYSDD QQVQDMAREM HDVNSSNLIL SFWQEKAKDY FMAGPELLSL DLTEIYEDIW
     TPCLTKFLNF GNRIAVGQAC FKEVEEALVG CGETGEGDRL KKEFMLMATM LDGHNENWPE
     QRLKQIREYR CLYDAAESAE VILKLKDRLG LQGDFSHIHS LTLVRDDSFK QNTLGSLSED
     LIKARQKLAD VERRHTACLE AFLKSDTLIK WIKAEIPSLK ELKVFMELAT ISAGENDADI
     DRLASFETAV MGYAPLLYSL PQNVGFEEFF DYAKQVLDTL NKDEKLGDKL VDSNRWLDWL
     KGLRETHGSV EQSSLSLASA INTGGVYHVG WPDDFNGKTG LDNIFYVKVT KNNEEKTYRL
     NELLELQNKL MLMSSKGEKG KEQVIKFTQV FEGIQRMGRI LLQLHRSGNM LFRNWAAEIT
     CNHQNQPCIQ VKFPLLSKCI VYQGEVEEEL QKLSRSLEDF HKDWCNHLTK MRSQYYPLNH
     YSSEQIVYLC EWINSINIKK KPVPQQVWHL LTPIKPDCML NDIKEAFEIA TEPQSILQED
     TAEELGPNSD FDLPLSFSLL DVSTECLEDL WKQFKENMSG FLTHHVDVET LGRFLSNLSN
     MNQLHIKRKI PSFLQEGRPN LVQCPAAELM STTLSFYMES PENPLPTTDE VLMCQEETTE
     EEVEIFLRRC LGGAASNHKK IYTLVNPGSM SYDVSVALVE YFETQEVCAG PYYRLVMVCP
     VNQDRYIPSF FSNYKVQTGI TISAERSQKY IRHHFKISYE LATHSSVYPE RLSVWMIASK
     RPAVGKSLYV RRLFEKFKGE FPRATLLTIR LIDPYIDMDG FVQTLSERLA PLRQQDPVLL
     HIDVAAVCHG LEEFLFKLLI LECISDSKGT IWRRNKAHLV VIETLQRGHK TQTKMEPSHG
     FLNTLPTIFC RPPKDIKEIM KTNESFRSLD PLMDKEEFES EDIQRPYQYL RRFNRSMNLD
     RFTYQAHSVE GDPVDCLHHL LSNYGLKDPS WAELKHFTWF LNLQLKDCEK SLFCDSDFCG
     ETLSGFKDFI VKFMIHMARD FASPSIDISD QSPSFFSKNE DEEEILSFRK RWENESHPYI
     FFNADHVSMS FLGFHVKQNG TILNAVDSKS GKVLMRNVMT QELFSDIQRQ MINLSKDFDD
     LTREDKLQKM SFVVGAEKGC EKGKFDPDPT YELTTDNVMK MLAIHMRFRC EIPVIIMGET
     GCGKTRLVRF LCDLQREGRD VENMKLVKVH GGTTSETIYK KVREAEELAQ KNRQKYKLDT
     VLFFDEANTT EAIFAIKEVL CDKTVKGYPL KKNSGLKIIA ACNPYRRHTT KMVDRLERAG
     LGYRVKAEET EDRLGKVPMR QLVYRVHPLP PSMVPLVWDF GQLSDSTELS YIRQIVKKKM
     RDHRLPLSCQ NVITNVLAAS QKYMRNQADE CSFVSLRDVE RSMGVLLWFY NHRDIFFPSQ
     DFPRFENVQM VLKCLVLAVG VCYYPSLENK RPYLATISKC FPDQFNSEES LEQEIASCQD
     FLLKNIQTRE TIAKNMALKE NVFLMVVCIE LRIPLFLVGK PGSSKSLAKT VIADAMQRQA
     SHCDLFKKLK EVHMVSFQCS PHSSPEGIIG TFRNCARFQK DKNLDEYVSV VVLDEIGLAE
     DSPQMPLKTL HPLLEDGCID SDNPESYMKV GFVGISNWAL DPAKMNRGIF VSRWDPSEKD
     LVETAEGICS SSQPVLLKIK HLLSKLAKCF LSICKTDSEQ FFGLRDYYGL IKMLFDTVKC
     SDQEPSDKEL AEAVLRNFSG QRDGFDPLDY FKDIFQNIQN VQRPNTLNMI EQNLDHHIDK
     ECRYLLLLTT NNAALYIIQH HIFSKENYTQ KCPEIVFGSG FPKDQEYAQI CRNVSRIKAC
     METGRTVILL NLLNLYESLY DALNQYYVYF SGQQYVDLGL GSHRVKCRVH RDFRLVVVED
     QEKVYKKFPV PLKNRLEKHK VDRSTDLAPW QHRVLEKLKK WAREFSKIQH SDSSEANFSV
     TDAFVGFHGD ACASALLQAL KKIDKLHHNK EENREESEAH HIDREFTEFQ EKVNKFPDEA
     QEDDASMEVD KVQDAEIDEE METLEDDSDL VKMVEGPVFV ETRDKIESNK TMDEEEVYEI
     AKSFLLNCST PDSVLRLKYS EFGNQETEEL QKMYFHLQTH QSLRDLLNNH LNKTNQDKNR
     FLEVTTFSNL LTGADVRNLG PALGLSTERF LLLSLHQFDT EASFCNKIQS FLRESGPSVH
     ILLIQMDMEE SLCKNELIAS AKYCTMNEIL HLKSDECNIY TVFITKLSRI GEQCTSITGD
     KYIGFQGGVW LSAHIDDLRD SDDLCLNLKA FCGIPISQLI SQTIESDVKE SDEMNTNRQQ
     SEKGDSVHLH SLSLLRSCTQ KAVSLLRDTD EKTSRSMERM NILLGLLACD PGRTGARFQQ
     VLLKRLVFAL IQKEELIPNA KDWVYKVAKN HEALQECGTL RHTLWRYLQD FLTPVLARIL
     EVIDRDCNLY QLYGEGLSEG LTQFWLDIFE DQQLLDLIPS QNTRAPDQEI NVQCHLFVGE
     VEQPCAAPYS WLIKTYCQSL WEESEFVRSS EQDIKARIQQ FVSAVSGSRL GSYIQKLSDV
     ENVELGQRYL TDYVLLAFKV NSEDEHWVLQ SAVLGCVFTL QTMMSVSPEL SPSWIHAAAQ
     IYNPRMDTLS HVLQLNPQLV SLIQQERPKR ESPDMCEDIL AVGICVEETK LLPVTSLTEC
     LTFLQRVEQL QPCIERVLSP DYSALCSPGC LKYLETIQSV WQGILLVAVF IEKVVIKMKK
     GDERIIALTL KHCSQLHGLV EGSPDFRSKD NLQQIIRILN DYHEESISSE LRYGVKCRVC
     LMELSEPFAL PCEHVFCRSC LRRSMEREEA QHCPVCREPL SNNYQPTVST TLNYSFALKQ
     HKEIIKCCNT FFLEVVSRFC LTDDQDPPDD LVELLFSLLI SAQGDVYKTR ELTPFLECVD
     QSPVVRSVLP KLLMQYSLKQ VKKHIQSYLE DLENKLLDKE DRTELYRLFV NCFQDTLLCS
     DSNGDHKHLR ENTNFLSRLA RKQTPSRQND PAEFLMSMAR LRMCLDSAAY ILSKAICQKN
     NFVEAEFKFM EQVKAVCDYC DNDWYRVYLL RALNRQAGMD FLQALINSTD YEWIFPAEMM
     RLHRLIPAEV DRFLCCGQSY RALRDGVGES TQVGTTDGLK EALQASVGSS PLKNALLTLA
     VFRQVTCHFM SPERTLHPQE QQISILEKVI RDNMSGHARE FCTALLSNHI GGPGSNLRLG
     TGVPAQRRPV LELLVHACTV FYSGNRLISP LFNIASQPQN MTGAFLPTMP DDHTSEAKQW
     LSEKKLKMYF CSNSHACFVG ECGRPMAKSK CATCGVEIGG EGHIPVPGFT EAYGDYDRTR
     PGHILGQART RSEAPNRKLT LAQSCVLRLC LHLAMLQGLI HYQQGIRNMI HPEVSDVYQF
     LWQHLEKDME VLGKTLTLNI DDSAIVIHLI FSRFLQTTPV ANVDLSTRKS REQWEITVCK
     TAISPVLQNL DRELNNAQDL IAADNRLSNS PLVKVLRGDP QRMLQLPANC PTEHSAFWSP
     SSVLAVESIS QQIDQAQAPL LTLFVQKVHY IRQLDCLPAL AALLSDLIKV LPPGSETQNH
     TIASLLHCIP AGHQKKLMSE RVEIYMKVWN QLRMEISSNA SLGLDSTHCE KDITSESSGQ
     FLFPSRKGAG SCLHAVIDVL SETHNSLVRE ARKLCQQTDS DYKVPLAVLS KSQLALCHPE
     REFLPLVLAN CHYTLEKGQQ TVSSYDHQGI ERELSRRFFA GKPRIQTDTE KYLRRHHQNF
     TEVLNEVRAK IPQEMFWNPK QIHQAFSTNY HSTNRHKGLS RFYPDQPLSI TTVPDLVIPR
     RPVGFQTQER HTLTPPGSHL TALNSLPAFS FCAPPISIRS TMELHLEEKD ITSFPGLDSL
     PEELTWAKAA EIWRLAVQFK H
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024